Eurotechnology Japan KK

Eurotechnology Japan KK is a Tokyo-based advisory and small-investment vehicle led by Gerhard Fasol, better known for decades of cross-border consulting between European technology companies and the Japanese market than for institutional venture capital. The firm’s public profile suggests strategic advisory, occasional angel checks, and bridge-building for Western firms entering Japan, rather than a thesis-led healthcare fund. Healthcare exposure is incidental; any check would likely come because a Western digital health, medtech, or AI company needs a Japanese landing partner and is willing to give Fasol a small allocation in exchange for market access, partnership introductions to Japanese pharma, payors, or distributors, and regulatory navigation. AI focus is unstated and likely opportunistic. Expect angel-scale checks of roughly USD 25K to USD 250K, almost always as a co-investor, never as a lead. This is the wrong door for founders who simply want a priced-round lead or a US-style growth partner. It is a plausible door for European or US digital health and medtech teams that have raised a seed or Series A and are seriously planning Japan entry, where Fasol’s network into corporate Japan is the actual product. Entry path is the company website or a direct LinkedIn message; founders should lead with a specific Japan thesis and a clear ask, not a generic fundraising pitch. Treat the check as a side effect of the relationship, not the headline.